Trial Profile
Study to evaluate the incidence and etiologies of proteinuria in renal transplant recipients on treatment with a belatacept based regimen
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- 21 Aug 2015 New trial record